Baxter International (BAX) Operating Expenses (2009 - 2026)

Baxter International (BAX) has reported Operating Expenses for 18 consecutive years, with $864.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 1.41% year-over-year to $864.0 million in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 17.61% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 4.19% from the prior year.
• Operating Expenses was $864.0 million for Q2 2026 at Baxter International, roughly flat from $867.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $1.2 billion in Q1 2024 and troughed at $15.0 million in Q4 2023.
• A 5-year average of $896.4 million and a median of $1.1 billion in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 59.21% in 2022 and sank 89.36% in 2023, its largest moves.
• Over 5 years, Operating Expenses stood at $141.0 million in 2022, then slumped by 89.36% to $15.0 million in 2023, then soared by 7920.0% to $1.2 billion in 2024, then fell by 29.18% to $852.0 million in 2025, then climbed by 1.41% to $864.0 million in 2026.
• The last three Operating Expenses figures came in at $864.0 million (Q2 2026), $867.0 million (Q1 2026), and $852.0 million (Q2 2025), per Business Quant data.